Market opportunities for mRNA synthesis raw materials lie in the growing demand for high-purity materials driven by mRNA therapeutics. Key drivers include advancements in mRNA technology, regulatory ...

Researchers have launched HTGAnalyzer, a new, easy-to-use, fast and reproducible bioinformatics tool for advanced ...

"People are going to die because we're cutting short funding for this technology," Dr. Jerome Adams said in an interview with CBS News on Aug. 10.

Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful ...

CDC employees across all of the agency’s campuses will be teleworking today, after a gunman shot multiple rounds into four ...

THESE WERE JUST THREE of the specious claims Kennedy made; there were others, too. But it’s likely that for many people who ...

CureVac ( (CVAC)) has provided an announcement. On August 7, 2025, CureVac announced the resolution of U.S. patent litigation with Pfizer/BioNTech concerning mRNA-based COVID-19 vaccines. As part of ...

HHS Secretary Robert F Kennedy Jr has canceled nearly $500 million in grants and contracts meant to support mRNA vaccine development.

Company to Webcast Investor Event on August 30, 2025, at 1:00 p.m. EDT (7:00 pm CEST)- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that ...

A team of researchers at UT developed a new artificial intelligence model that can assist in vaccine and drug discovery by predicting specific genetic sequences, according to a paper published July 25 ...